Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 8937 | 1135 | 35.3 | 69% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | METFORMIN | Author keyword | 84 | 16% | 44% | 496 |
| 2 | LACTIC ACIDOSIS | Author keyword | 19 | 16% | 9% | 105 |
| 3 | METFORMIN ASSOCIATED LACTIC ACIDOSIS | Author keyword | 8 | 100% | 0% | 5 |
| 4 | BIGUANIDES | Author keyword | 6 | 21% | 2% | 23 |
| 5 | BIGUANIDE | Author keyword | 4 | 20% | 1% | 17 |
| 6 | EXTENDED RELEASE METFORMIN | Author keyword | 3 | 100% | 0% | 3 |
| 7 | NAZL INFORMAZ TOSSICOL | Address | 3 | 100% | 0% | 3 |
| 8 | BOWEL UPTAKE | Author keyword | 3 | 60% | 0% | 3 |
| 9 | CAS 657 24 9 | Author keyword | 2 | 67% | 0% | 2 |
| 10 | ORAL ANTI DIABETIC THERAPY | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | METFORMIN | 84 | 16% | 44% | 496 | Search METFORMIN | Search METFORMIN |
| 2 | LACTIC ACIDOSIS | 19 | 16% | 9% | 105 | Search LACTIC+ACIDOSIS | Search LACTIC+ACIDOSIS |
| 3 | METFORMIN ASSOCIATED LACTIC ACIDOSIS | 8 | 100% | 0% | 5 | Search METFORMIN+ASSOCIATED+LACTIC+ACIDOSIS | Search METFORMIN+ASSOCIATED+LACTIC+ACIDOSIS |
| 4 | BIGUANIDES | 6 | 21% | 2% | 23 | Search BIGUANIDES | Search BIGUANIDES |
| 5 | BIGUANIDE | 4 | 20% | 1% | 17 | Search BIGUANIDE | Search BIGUANIDE |
| 6 | EXTENDED RELEASE METFORMIN | 3 | 100% | 0% | 3 | Search EXTENDED+RELEASE+METFORMIN | Search EXTENDED+RELEASE+METFORMIN |
| 7 | BOWEL UPTAKE | 3 | 60% | 0% | 3 | Search BOWEL+UPTAKE | Search BOWEL+UPTAKE |
| 8 | CAS 657 24 9 | 2 | 67% | 0% | 2 | Search CAS+657+24+9 | Search CAS+657+24+9 |
| 9 | ORAL ANTI DIABETIC THERAPY | 2 | 67% | 0% | 2 | Search ORAL+ANTI+DIABETIC+THERAPY | Search ORAL+ANTI+DIABETIC+THERAPY |
| 10 | PHENFORMIN | 2 | 20% | 1% | 9 | Search PHENFORMIN | Search PHENFORMIN |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BIGUANIDES | 33 | 50% | 4% | 47 |
| 2 | CONTRAINDICATIONS | 10 | 24% | 3% | 36 |
| 3 | INDUCED LACTIC ACIDOSIS | 7 | 36% | 1% | 15 |
| 4 | INTRACELLULAR POOL | 6 | 26% | 2% | 18 |
| 5 | PHENFORMIN | 5 | 30% | 1% | 13 |
| 6 | LOW DOSE METFORMIN | 4 | 75% | 0% | 3 |
| 7 | OBESE NONDIABETIC SUBJECTS | 4 | 75% | 0% | 3 |
| 8 | INSULIN RECEPTOR BINDING | 3 | 35% | 1% | 8 |
| 9 | FREMANTLE | 3 | 100% | 0% | 3 |
| 10 | PROLONGED HEMODIALYSIS | 2 | 67% | 0% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Drug therapy - Metformin | 1996 | 980 | 52 | 65% |
| Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency | 2011 | 89 | 43 | 65% |
| Metformin: An update | 2002 | 444 | 93 | 52% |
| Clinical Pharmacokinetics of Metformin | 2011 | 158 | 80 | 35% |
| Metformin and other antidiabetic agents in renal failure patients | 2015 | 6 | 110 | 29% |
| Metformin in Patients With Type 2 Diabetes and Kidney Disease A Systematic Review | 2014 | 12 | 66 | 86% |
| Acute Metformin Overdose: Examining Serum pH, Lactate Level, and Metformin Concentrations in Survivors Versus Nonsurvivors: A Systematic Review of the Literature | 2009 | 35 | 6 | 83% |
| Metformin and lactic acidosis: cause or coincidence? A review of case reports | 2004 | 95 | 31 | 94% |
| Metformin revisited: A critical review of the benefit-risk balance in at-risk patients with type 2 diabetes | 2013 | 36 | 83 | 40% |
| Metformin-Associated Lactic Acidosis | 2015 | 1 | 38 | 74% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | NAZL INFORMAZ TOSSICOL | 3 | 100% | 0.3% | 3 |
| 2 | COMPARAT BIOCHEM PHYSIOL | 2 | 50% | 0.3% | 3 |
| 3 | DINO FERRARIDIPARTIMENTO SCI NEUROL | 1 | 50% | 0.2% | 2 |
| 4 | INT PHARMACOL SUPPORT | 1 | 100% | 0.2% | 2 |
| 5 | LYONNAISE IND PHARMACEUT | 1 | 100% | 0.2% | 2 |
| 6 | METAB CLIN DESIGN EVALUAT | 1 | 100% | 0.2% | 2 |
| 7 | ANESTHESIA INTENS | 1 | 50% | 0.1% | 1 |
| 8 | ARRHYTHMIA MANAGEMENT CLIN OUTCOMES | 1 | 50% | 0.1% | 1 |
| 9 | ATENC PRIMARIA LA MINA | 1 | 50% | 0.1% | 1 |
| 10 | BEIJING CHAOYANG HOSP AFFILIATED | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000138728 | GLIMEPIRIDE//JTT 608//SECONDARY FAILURE |
| 2 | 0.0000134366 | METFORMIN HYDROCHLORIDE//PIOGLITAZONE HYDROCHLORIDE//ROSIGLITAZONE MALEATE |
| 3 | 0.0000110810 | NATEGLINIDE//KAD 1229//REPAGLINIDE |
| 4 | 0.0000108224 | PIOGLITAZONE//ROSIGLITAZONE//THIAZOLIDINEDIONES |
| 5 | 0.0000098774 | TROGLITAZONE//JTT 501//CAS 97322 87 7 |
| 6 | 0.0000096658 | TYPE B LACTIC ACIDOSIS//SODIUM DICHLOROACETATE DCA//ACID BASE EQUILIBRIUM METABOLIC ACIDOSIS |
| 7 | 0.0000089392 | INSULIN GLARGINE//INSULIN DETEMIR//BIPHASIC INSULIN ASPART 30 |
| 8 | 0.0000083074 | ACARBOSE//ALPHA GLUCOSIDASE INHIBITOR//MIGLITOL |
| 9 | 0.0000080093 | AMPK//AMP ACTIVATED PROTEIN KINASE//AICAR |
| 10 | 0.0000079733 | GLICLAZIDE//INTERNAL MED DIABETOL CLIN PHARMACOL//DRUG QUAL CONTROL PHARMACOVIGILANC |